Home > Cardiology > ACC 2019 > Heart Failure and Cardiomyopathies > Frequent use of beta-blocker after HFpEF hospitalisations in elderly patients without compelling indications

Frequent use of beta-blocker after HFpEF hospitalisations in elderly patients without compelling indications

Expert
Dr Brian Yum, Weill Cornell Medicine, USA
Conference
ACC 2019
Trial
Cohort study, REGARDS

Older adults who suffer from heart failure with preserved ejection fraction (HFpEF) are frequently prescribed beta-blockers despite limited data to show their benefit in HFpEF [1]. Moreover, there is evidence suggesting that these agents can worsen geriatric conditions in this population by exacerbating chronotropic incompetence.

Dr Brian Yum (Weill Cornell Medicine, USA) and colleagues examined a subset of data from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. REGARDS is an observational, population-based cohort study including 30,000 individuals aged ≥45 years designed to identify factors that contribute to the excess stroke mortality in Southeastern USA and in African Americans. Yum et al. examined 316 adults aged >65 years with an adjudicated HFpEF hospitalisation to gain insights into indications for beta-blockers use among older adults hospitalised with HFpEF. The presence of a history of myocardial infarction (MI),...



please login to read the entire article:


You need to register to read the entire article, please do so now.





Posted on